Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 4:2018:1205121.
doi: 10.1155/2018/1205121. eCollection 2018.

Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability

Affiliations
Review

Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability

A K J Gradel et al. J Diabetes Res. .

Abstract

Variability in the effect of subcutaneously administered insulin represents a major challenge in insulin therapy where precise dosing is required in order to achieve targeted glucose levels. Since this variability is largely influenced by the absorption of insulin, a deeper understanding of the factors affecting the absorption of insulin from the subcutaneous tissue is necessary in order to improve glycaemic control and the long-term prognosis in people with diabetes. These factors can be related to either the insulin preparation, the injection site/patient, or the injection technique. This review highlights the factors affecting insulin absorption with special attention on the physiological factors at the injection site. In addition, it also provides a detailed description of the insulin absorption process and the various modifications to this process that have been utilized by the different insulin preparations available.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An overview of the layers of the skin and muscle. Upon injection into the subcutaneous compartment, insulin can either be absorbed by blood capillaries (red) and/or lymphatic capillaries (green). Adapted with permission from Taylor & Francis and Frost GI: Recombinant human hyaluronidase (rHuPH20): An enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv (2007) 4(4):427–440. © 2007 Taylor & Francis.
Figure 2
Figure 2
Relationship between the insulin oligomers (monomers, dimers, and hexamers) and the equilibrium constants KDH and KMD. Adapted and printed with permission from Elsevier and Rasmussen: Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms. Eur J Pharm Sci (2014) 62: 65–75. © 2014 Elsevier.
Figure 3
Figure 3
Relative abundance (%) of insulin hexamers, dimers, and monomers as a function of total concentration Cτ. Printed with permission from Elsevier and Søeborg: Absorption kinetics of insulin after subcutaneous administration. Eur J Pharm Sci (2009) 36: 78–90. © 2009 Elsevier.

References

    1. Owens D. R., Zinman B., Bolli G. B. Insulins today and beyond. The Lancet. 2001;358(9283):739–746. doi: 10.1016/S0140-6736(01)05842-1. - DOI - PubMed
    1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977–986. doi: 10.1056/nejm199309303291401. - DOI - PubMed
    1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet. 1998;352(9131):837–853. doi: 10.1016/S0140-6736(98)07019-6. - DOI - PubMed
    1. Brownlee M., Hirsch I. B. Glycemic variability: a hemoglobin A1c–independent risk factor for diabetic complications. JAMA. 2006;295(14):1707–1708. doi: 10.1001/jama.295.14.1707. - DOI - PubMed
    1. Nalysnyk L., Hernandez-Medina M., Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes, Obesity and Metabolism. 2010;12(4):288–298. doi: 10.1111/j.1463-1326.2009.01160.x. - DOI - PubMed